EDGAR Filing Documents for 0001136261-21-000248

Form 8-K - Current report:

SEC Accession No. 0001136261-21-000248

Filing Date

2021-11-24

Accepted

2021-11-24 07:27:20

Documents

Period of Report

2021-11-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	35792
2	FORM OF CONVERTIBLE PROMISSORY NOTE	exh4-1.htm	EX-4.1	169692
3	SECURITIES PURCHASE AGREEMENT	exh10-1.htm	EX-10.1	217872
4	SECURITY AGREEMENT	exh10-2.htm	EX-10.2	91674
5	PRESS RELASE	exh99-1.htm	EX-99.1	13767
6	GRAPHIC	image4190.jpg	GRAPHIC	3218
	Complete submission text file	0001136261-21-000248.txt		833692

Data Files

Seq	Description	Document	Type	Size
7	XBRL SCHEMA FILE	seel-20210614.xsd	EX-101.SCH	3025
8	XBRL LABEL FILE	seel-20210614_lab.xml	EX-101.LAB	34240
9	XBRL PRESENTATION FILE	seel-20210614_pre.xml	EX-101.PRE	22359
10	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3889

Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022

Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100

SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)